Home > Insider Trading > Filing (0001138723-10-000102)

Filing Details

Accession Number:: 0001138723-10-000102
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-19 19:51:26
Reporting Period:: 2010-11-17

Filing Date:: 2010-11-19
Accepted Time:: 2010-11-19 19:51:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138723	Accuray Inc	ARAY	Surgical & Medical Instruments & Apparatus (3841)	770268932

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1387516	Euan Thomson	1310 Chesapeake Terrace Sunnyvale CA 94089	President & Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-11-17	12,500	$0.75	145,800	No	4	M	Direct
Common Stock	Disposition	2010-11-17	12,500	$5.91	133,300	No	4	S	Direct
Common Stock	Acquisiton	2010-11-18	12,500	$0.75	145,800	No	4	M	Direct
Common Stock	Disposition	2010-11-18	12,500	$5.97	133,300	No	4	S	Direct
Common Stock	Acquisiton	2010-11-18	10,000	$0.75	143,300	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Disposition	2010-11-17	12,500	$0.00	12,500	$0.75
Common Stock	Incentive Stock Option (right to buy)	Disposition	2010-11-18	12,500	$0.00	12,500	$0.75
Common Stock	Incentive Stock Option (right to buy)	Disposition	2010-11-18	10,000	$0.00	10,000	$0.75

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
120,832	2012-03-28	No	4	M	Direct
108,332	2012-03-28	No	4	M	Direct
98,332	2012-03-28	No	4	M	Direct

Footnotes

A portion of these options are being sold so that a portion of the proceeds may be used to increase the CEO's ownership of Accuray stock in accordance with the adoption of stock ownership guidelines for management by the Board of Directors of Accuray Incorporated in fiscal year 2011.
A total of 12,500 shares were sold pursuant to a 10b5-1 Plan, at an average sale price of $5.9096 per share. The actual sale price for the shares was: 200 shares at $5.8702; 200 shares at $5.8705; 2,500 shares at $5.8750; 2,200 shares at $5.88; 200 shares at $5.89; 854 shares at $5.90; 100 shares at $5.9001; 100 shares at $5.9002; 1,000 shares at $5.91; 200 shares at $5.9101; 100 shares at $5.9103; 400 shares at $5.92; 1,500 shares at $5.93; 200 shares at $5.9303; 200 shares at $5.9305; 200 shares at $5.9313; 446 shares at $5.94; 518 shares at $5.95; 100 shares at $5.9501; 100 shares at $5.9504; 100 shares at $5.9550; 100 shares at $5.97; 100 shares at $5.98; 682 shares at $5.99; 200 shares at $6.00.
A total of 12,500 shares were sold pursuant to a 10b5-1 Plan, at an average sale price of $5.9713 per share. The actual sale price for the shares was: 4,157 shares at $5.95; 3,900 shares at $5.96; 100 shares at $5.9601; 100 shares at $5.9603; 100 shares at $5.97; 100 shares at $5.9701; 300 shares at $5.9703; 200 shares at $5.9706; 200 shares at $5.9709; 100 shares at $5.9710; 370 shares at $5.98; 200 shares at $5.99; 50 shares at $6.00; 678 shares at $6.01; 300 shares at $6.0101; 200 shares at $6.0112; 615 shares at $6.02; 300 shares at $6.0201; 100 shares at $6.03; 300 shares at $6.04; 130 shares at $6.05.
The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.